Passage Bio Inc (PASG) — Cash Flow-to-Debt Ratio
Latest as of March 2026:
-0.53x
Passage Bio Inc (PASG) has a Cash Flow-to-Debt Ratio of -0.53x as of March 2026, meaning its operating cash flow of $-12.99 Million could theoretically repay -1% of its total liabilities ($24.71 Million) in one year. See PASG FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-0.53x
Operating CF / Total Liabilities
Operating Cash Flow
$-12.99 Million
USD
Total Liabilities
$24.71 Million
USD
Data as of
Mar 2026
Most recent filing
Passage Bio Inc Cash Flow-to-Debt Ratio (2018–2025)
Historical debt coverage capacity for Passage Bio Inc across 8 annual periods. For the full cash flow conversion analysis, see Passage Bio Inc operating cash flow efficiency.
Annual Cash Flow-to-Debt Ratio for Passage Bio Inc (2018–2025)
Year-by-year debt coverage analysis for Passage Bio Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.72x | $-31.51 Million | $43.53 Million | ▲ +37.9% |
| 2024 | -1.17x | $-47.96 Million | $41.15 Million | ▲ +41.5% |
| 2023 | -1.99x | $-78.26 Million | $39.26 Million | ▲ +28.9% |
| 2022 | -2.80x | $-118.21 Million | $42.18 Million | ▲ +19.6% |
| 2021 | -3.48x | $-126.88 Million | $36.42 Million | ▼ -0.8% |
| 2020 | -3.46x | $-80.52 Million | $23.29 Million | ▲ +63.1% |
| 2019 | -9.36x | $-39.90 Million | $4.26 Million | ▼ -2201.3% |
| 2018 | -0.41x | $-18.57 Million | $45.63 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.